Compound ID | 1408
Class: Phenothiazine
| Spectrum of activity: | Gram-positive |
| Details of activity: | MRSA. Has also shown to make MRSA sensitive to Beta-lactam antibiotics |
| Institute where first reported: | Novartis, Switzerland |
| Highest development stage: | Approved by FDA in 1962 |
| Development status: | Withdrawn |
| Reason dropped: | Caused severe cardiac arrhythmias |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5452 |
| Guide to Pharmacology: | thioridazine |
| Citations: |
|